170 related articles for article (PubMed ID: 34768912)
41. Host Cxcr2-dependent regulation of mammary tumor growth and metastasis.
Sharma B; Nannuru KC; Varney ML; Singh RK
Clin Exp Metastasis; 2015 Jan; 32(1):65-72. PubMed ID: 25511644
[TBL] [Abstract][Full Text] [Related]
42. CCL2 Is a Vascular Permeability Factor Inducing CCR2-Dependent Endothelial Retraction during Lung Metastasis.
Roblek M; Protsyuk D; Becker PF; Stefanescu C; Gorzelanny C; Glaus Garzon JF; Knopfova L; Heikenwalder M; Luckow B; Schneider SW; Borsig L
Mol Cancer Res; 2019 Mar; 17(3):783-793. PubMed ID: 30552233
[TBL] [Abstract][Full Text] [Related]
43. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
44. Vascular adaptation to a dysfunctional endothelium as a consequence of Shb deficiency.
Christoffersson G; Zang G; Zhuang ZW; Vågesjö E; Simons M; Phillipson M; Welsh M
Angiogenesis; 2012 Sep; 15(3):469-80. PubMed ID: 22562363
[TBL] [Abstract][Full Text] [Related]
45. Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy.
Uribesalgo I; Hoffmann D; Zhang Y; Kavirayani A; Lazovic J; Berta J; Novatchkova M; Pai TP; Wimmer RA; László V; Schramek D; Karim R; Tortola L; Deswal S; Haas L; Zuber J; Szűcs M; Kuba K; Dome B; Cao Y; Haubner BJ; Penninger JM
EMBO Mol Med; 2019 Aug; 11(8):e9266. PubMed ID: 31267692
[TBL] [Abstract][Full Text] [Related]
46. CXCL17-derived CD11b
Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
[TBL] [Abstract][Full Text] [Related]
47. Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors.
Ryzhov SV; Pickup MW; Chytil A; Gorska AE; Zhang Q; Owens P; Feoktistov I; Moses HL; Novitskiy SV
J Immunol; 2014 Sep; 193(6):3155-64. PubMed ID: 25127858
[TBL] [Abstract][Full Text] [Related]
48. Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling.
Rolny C; Lu L; Agren N; Nilsson I; Roe C; Webb GC; Welsh M
Exp Cell Res; 2005 Aug; 308(2):381-93. PubMed ID: 15919073
[TBL] [Abstract][Full Text] [Related]
49. Recombinant virus-like particles presenting IL-33 successfully modify the tumor microenvironment and facilitate antitumor immunity in a model of breast cancer.
Feng X; Liu H; Chu X; Sun P; Huang W; Liu C; Yang X; Sun W; Bai H; Ma Y
Acta Biomater; 2019 Dec; 100():316-325. PubMed ID: 31542504
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer.
Liu JF; Deng WW; Chen L; Li YC; Wu L; Ma SR; Zhang WF; Bu LL; Sun ZJ
Mol Carcinog; 2018 Mar; 57(3):429-439. PubMed ID: 29215754
[TBL] [Abstract][Full Text] [Related]
51. The SHB adapter protein is required for normal maturation of mesoderm during in vitro differentiation of embryonic stem cells.
Kriz V; Agren N; Lindholm CK; Lenell S; Saldeen J; Mares J; Welsh M
J Biol Chem; 2006 Nov; 281(45):34484-91. PubMed ID: 16971391
[TBL] [Abstract][Full Text] [Related]
52. TLR8 ligation induces apoptosis of monocytic myeloid-derived suppressor cells.
Dang Y; Rutnam ZJ; Dietsch G; Lu H; Yang Y; Hershberg R; Disis ML
J Leukoc Biol; 2018 Jan; 103(1):157-164. PubMed ID: 29345064
[TBL] [Abstract][Full Text] [Related]
53. Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment.
Qu P; Wang LZ; Lin PC
Cancer Lett; 2016 Sep; 380(1):253-6. PubMed ID: 26519756
[TBL] [Abstract][Full Text] [Related]
54. Suppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis.
Ma Z; Gibson SL; Byrne MA; Zhang J; White MF; Shaw LM
Mol Cell Biol; 2006 Dec; 26(24):9338-51. PubMed ID: 17030605
[TBL] [Abstract][Full Text] [Related]
55. Fes tyrosine kinase expression in the tumor niche correlates with enhanced tumor growth, angiogenesis, circulating tumor cells, metastasis, and infiltrating macrophages.
Zhang S; Chitu V; Stanley ER; Elliott BE; Greer PA
Cancer Res; 2011 Feb; 71(4):1465-73. PubMed ID: 21159660
[TBL] [Abstract][Full Text] [Related]
56. Loss of endothelial EMCN drives tumor lung metastasis through the premetastatic niche.
Zhang G; Li M; Zhou D; Yang X; Zhang W; Gao R
J Transl Med; 2022 Oct; 20(1):446. PubMed ID: 36184589
[TBL] [Abstract][Full Text] [Related]
57. The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration.
Holmqvist K; Cross MJ; Rolny C; Hägerkvist R; Rahimi N; Matsumoto T; Claesson-Welsh L; Welsh M
J Biol Chem; 2004 May; 279(21):22267-75. PubMed ID: 15026417
[TBL] [Abstract][Full Text] [Related]
58. Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia.
Jamalpour M; Li X; Cavelier L; Gustafsson K; Mostoslavsky G; Höglund M; Welsh M
Tumour Biol; 2017 Oct; 39(10):1010428317720643. PubMed ID: 28982308
[TBL] [Abstract][Full Text] [Related]
59. Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediators.
Owens P; Pickup MW; Novitskiy SV; Chytil A; Gorska AE; Aakre ME; West J; Moses HL
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2814-9. PubMed ID: 21576484
[TBL] [Abstract][Full Text] [Related]
60. POU1F1 transcription factor promotes breast cancer metastasis via recruitment and polarization of macrophages.
Seoane S; Martinez-Ordoñez A; Eiro N; Cabezas-Sainz P; Garcia-Caballero L; Gonzalez LO; Macia M; Sanchez L; Vizoso F; Perez-Fernandez R
J Pathol; 2019 Nov; 249(3):381-394. PubMed ID: 31292963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
